NeuroVive Redirects Research Resources From Asian Subsidiary to Parent
Under the agreement, NeuroVive Pharmaceutical AB will receive approximately 5 million SEK before transaction costs. In addition, NeuroVive and its collaboration partner Foundation Asia Pacific Ltd. will reacquire the Hong Kong based subsidiary, NeuroVive …
News story posted on 2017-01-25T07:42:00